Skip to main content
OpenTrials

Clinical trial condition

Glycogen Storage Disease Type II

Explore clinical trials studying Glycogen Storage Disease Type II. Study availability and eligibility vary by location and protocol.

108 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Glycogen Storage Disease Type II trial results

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease

NCT07354724

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • University of California-Irvine Irvine, California, United States
  • Duke University School of Medicine - Early Phase Research Unit Durham, North Carolina, United States
  • The Lysosomal & Rare Disorders Research & Treatment Center Fairfax, Virginia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)

NCT07282847

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California, Irvine (UCI) Irvine, California, United States
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • NYU Langone New York, United States
View Trial Details
Recruiting

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

NCT07123155

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
Locations
  • University of California - Irvine Medical Center Irvine, California, United States
  • University of Florida (UF) - Gainesville Gainesville, Florida, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View all 28 locations
View Trial Details
Recruiting

Pompe Disease Registry Protocol

NCT00231400

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • University of Alabama at Birmingham- Site Number : 840106 Birmingham, Alabama, United States
  • Barrow Neurological Institute- Site Number : 840087 Phoenix, Arizona, United States
  • Phoenix Children's Hospital- Site Number : 840003 Phoenix, Arizona, United States
  • University of Arizona- Site Number : 840015 Tucson, Arizona, United States
View all 272 locations
View Trial Details
Recruiting

Pompe Pregnancy Sub-Registry

NCT00567073

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Barrow Neurol Group- Site Number : 840087 Phoenix, Arizona, United States
  • University of Florida Pediatrics Genetics- Site Number : 157138 Jacksonville, Florida, United States
  • Emory University School Of Medicine- Site Number : 840060 Atlanta, Georgia, United States
  • Indianapolis University School of Medicine- Site Number : 840027 Indianapolis, Indiana, United States
View all 35 locations
View Trial Details

Related conditions